Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.
about
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.Immunotherapy in Peripheral NeuropathiesSteroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.Drugs for the treatment of peripheral neuropathies.Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?Measuring disease activity and clinical response during maintenance therapy in CIDP: from ICE trial outcome measures to future clinical biomarkers.Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy.Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan.Polyneuropathies.
P2860
Q30397454-B2453CFF-9166-4F7E-802B-1ECEAB8F932DQ36484418-30549A58-EF27-4F15-8765-C26F5AFC47A5Q38599369-7406B756-9ED8-4C80-8DC1-B73D86C06745Q38633190-9D72A4FC-4E72-4748-B4E2-03466B4ED429Q38711142-16CFA2FF-EBD9-4FE1-8EC5-12A954A91C51Q38754861-4347AE06-1C3F-4806-BA1D-3E75820D8666Q38767133-F26CE72A-2013-4557-AEB9-1D6065497599Q38848521-889D03E4-804A-45D7-976B-D5B0C1AC0A66Q42225251-CC6E41BA-4444-4DB1-93AE-D59E38849C61Q47584292-9E0943C6-E4F3-4259-A916-92A3DFB703FFQ47585442-B4DCE5FE-09B0-4190-9B96-DC2DB0B215A1Q47978955-DE317503-E33F-45E2-9A5E-349B2DB03A8AQ48301410-1606DD93-7ACE-42B2-A9E0-2192D0D17B2AQ52686427-BBCA0B05-1FE0-456E-9E5F-97112D674714
P2860
Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Frequency and time to relapse ...... ed methylprednisolone in CIDP.
@en
Frequency and time to relapse ...... ed methylprednisolone in CIDP.
@nl
type
label
Frequency and time to relapse ...... ed methylprednisolone in CIDP.
@en
Frequency and time to relapse ...... ed methylprednisolone in CIDP.
@nl
prefLabel
Frequency and time to relapse ...... ed methylprednisolone in CIDP.
@en
Frequency and time to relapse ...... ed methylprednisolone in CIDP.
@nl
P2093
P2860
P50
P356
P1476
Frequency and time to relapse ...... sed methylprednisolone in CIDP
@en
P2093
Angelo Schenone
Antonino Uncini
Dario Cocito
Davide Pareyson
Fabio Giannini
Francesca Gallia
Giovanni Antonini
IMC Trial Group
Paolo Messina
Raffaella Fazio
P2860
P304
P356
10.1136/JNNP-2013-307515
P407
P50
P577
2014-09-22T00:00:00Z